Status:

COMPLETED

A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting

Lead Sponsor:

JOTEC GmbH

Conditions:

Type B Aortic Dissection

Eligibility:

All Genders

18+ years

Brief Summary

Cohort study according to national regulatory guidelines: Non-interventional, observational cohort study. Pair-matched comparison with patients chosen from historical series. To evaluate the clinical...

Eligibility Criteria

Inclusion

  • The clinical records of the patients mus support the following criteria:
  • Age \> 18 years
  • Type B dissection with expanding false lumen eligible for endovascular treatment which occured within 90 days prior to implantation
  • The endovascular treatment may be associated with a complementary surgical operation
  • The total diameter of the dissected aortic segment should not surpass 6cm, and have increased between 0.5 and 1cm within 1 month, prior to implantation
  • Visceral arteries involvement, i.e. perfusion of side branches via true or false lumen of type B dissection
  • Aortic kinking \< 90°
  • The patient must be available for the appropriate follow-up times for the duration of the study
  • Informed consent from patient or authorized relative
  • The data of whose patients clinical records confirm one of the following conditions will not be considered in this study:
  • Patients with a contraindication as indicated in the instruction for use
  • Patients with chronic thrombocytopenia or ongoing anticoagulation
  • Patients with renal failure and/or creatinine \>2.4mg/dl immediately before the intervention
  • Patients in whom the false lumen is completely thrombosed
  • Patients with ongoing infection
  • Patients with ongoing cancer
  • Patients who are enrolled in a clinical study
  • Aortic landing zone diameter over 40 mm
  • Potentially emboligenic iliac and aortic atheroma lesions
  • Associated pathology with life expectancy of less than 24 months
  • Unstable infectious syndrome

Exclusion

    Key Trial Info

    Start Date :

    November 1 2011

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2014

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT01407159

    Start Date

    November 1 2011

    End Date

    January 1 2014

    Last Update

    April 28 2014

    Active Locations (15)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 4 (15 locations)

    1

    Klinikum Augsburg

    Augsburg, Germany

    2

    German Heart Center

    Berlin, Germany, 13353

    3

    University Hospital

    Essen, Germany, 45147

    4

    University Hospital

    Freiburg im Breisgau, Germany